Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma - subgroup analysis of the PEVOsq basket trial

被引：0
|
作者：
Le Tourneau, C. [1 ]
Ghiringhelli, F. [2 ]
Saada, E. B. [3 ]
Chaltiel, R. [4 ]
Vansteene, D. [5 ]
Durando, X. [6 ]
You, B. [7 ]
Borel, C. [8 ]
Bigot, F. [9 ]
Abdeddaim, C. [10 ]
Marret, G. [11 ]
Jeannot, E. [12 ]
Rocco, E. Guerini [13 ]
Frige, G. [14 ]
Servant, N. [15 ]
Dupain, C. [16 ]
Kamal, M. [16 ]
Legrand, F. [17 ]
Jimenez, M. [17 ]
Filleron, T. [18 ]
机构：
[1] Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France
[2] Ctr Georges Francois Leclerc Dijon, Med Oncol, Dijon, France
[3] Ctr Anticancer Antoine Lacassagne, Med Oncol, Nice, France
[4] CHU Reims, Hop Robert Debre, Reims, France
[5] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France
[6] Ctr Jean PERRIN, F-63000 Clermont Ferrand, France
[7] HCL, Ctr Hosp Lyon Sud, Oncol Dept, Pierre Benite, France
[8] Ctr Lutte Canc, Ctr Paul Strauss, Med Oncol Dept, Strasbourg, France
[9] ICO Inst Cancerol Ouest, Dept Med Oncol, Site Paul Papin, Angers, France
[10] Ctr Oscar Lambret, Dept Med Oncol, Lille, France
[11] Inst Curie, Dept Drug Dev & Innovat, Paris, France
[12] Inst Curie, Pathol, Paris, France
[13] IEO Ist Europeo Oncol IRCCS, Dept Med Oncol, Milan, Italy
[14] IEO Ist Europeo Oncol, Expt Oncol, Milan, Italy
[15] Inst Curie, Dept Med Oncol, Paris, France
[16] Inst Curie, Drug Dev & Innovat Dept, Paris, France
[17] UNICANCER, R&D Dept, Paris, France
[18] IUCT Oncopole, Inst Claudius Regaud, Haute Garonne, Toulouse, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
923P
引用
收藏
页码：S583 / S583
页数：1
相关论文
共 50 条
  • [11] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [12] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
  • [13] POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck
    Forsyth, S.
    Yip, K.
    Foran, B.
    Gougis, P.
    Wheeler, G.
    White, L.
    Chandrakumar, A.
    Blair, K.
    Pathak, Y.
    Spanswick, V.
    Lowe, H.
    Hartley, J.
    Forster, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S686 - S687
  • [14] Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma
    Geiger, Jessica L.
    Bauman, Julie E.
    Gibson, Michael K.
    Gooding, William E.
    Varadarajan, Prakash
    Kotsakis, Athanasios
    Martin, Daniel
    Gutkind, Jorge Silvio
    Hedberg, Matthew L.
    Grandis, Jennifer R.
    Argiris, Athanassios
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (12): : 1759 - 1764
  • [15] Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
    Bhatia, Aarti
    Mehra, Ranee
    Bauman, Jessica
    Khan, Saad A.
    Wei, Wei
    Neumeister, Veronique
    Sandoval-Schaefer, Teresa
    Alpaugh, R. Katherine
    Lango, Miriam
    Rimm, David L.
    Ridge, John A.
    Burtness, Barbara
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
  • [16] A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Pfister, DG
    McCaffrey, J
    Zahalsky, AJ
    Schwartz, GK
    Lis, E
    Gerald, W
    Huvos, A
    Shah, J
    Kraus, D
    Shaha, A
    Singh, B
    Wolden, S
    Zelefsky, M
    Palgi, I
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (01) : 123 - 127
  • [17] A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
    David G. Pfister
    John McCaffrey
    Andrew J. Zahalsky
    Gary K. Schwartz
    Eric Lis
    William Gerald
    Andrew Huvos
    Jatin Shah
    Dennis Kraus
    Ashok Shaha
    Bhuvanesh Singh
    Suzanne Wolden
    Michael Zelefsky
    Ilana Palgi
    Investigational New Drugs, 2002, 20 : 123 - 127
  • [18] Interim analysis of the combination of durvalumab and cetuximab in a phase II trial of patients with recurrent and metastatic head and neck squamous cell carcinoma
    Gulati, Shuchi
    Palackdharry, Sarah
    Weatherford, Layne
    Wilson, Sarah
    Desai, Shireen
    Steele, Aubrey
    Riaz, Kashif
    Takiar, Vinita
    Draper, Trisha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [19] Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
    Tamaskovics, B. F.
    Hecht, M.
    Schubert, P.
    Kallies, A.
    Illmer, T.
    Radke, J.
    Koelbl, O.
    Steger, F.
    Brunner, T. B.
    Roedel, C.
    Fleischmann, M.
    Reinacher-Schick, A.
    Wingender, L. F.
    Melchior, P.
    Klautke, G.
    Hintzen, U.
    Gaipl, U. S.
    Haussmann, J.
    Budach, W.
    Fietkau, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S593 - S593
  • [20] Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
    Cohen, EEW
    Rosen, F
    Stadler, WM
    Recant, W
    Stenson, K
    Huo, DZ
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1980 - 1987
12345